What we know about the Chinese vaccine "Sinovac"

 In light of the emergence of the new Corona virus, all countries of the world are seeking today to devote all their scientific efforts to combat this dreadful epidemic that threatened and killed many of us for more than a year so far and is still doing, with research, studies and experiments, recently several countries showed their discovery and invention of vaccines against the Corona virus among those Countries China was the first country to have symptoms of the Coronavirus.

China recently released two vaccines, they were named: Sinovac and Sinopharma. It is likely that the SPNOVAC vaccine is more effective than Sinopharm, and it has been exported to several countries: Indonisia, Turkey, Brazil, Morocco, and recently batches were sent as a gift of affection to Algeria.

How does this vaccine work:

As this vaccine depends on the traditional method of killing viruses, by treating it with an anti-virus substance, so the vaccine discourages the virus from multiplying and spreading in the human body. The human being gets immunity to the various virus proteins.

The effectiveness of the Sinovac vaccine:

It was announced that the effectiveness of this vaccine reaches 90%, but this number is deduced from experiments conducted on a small number of people who had volunteered for this experiment in Turkey. When the effectiveness of the vaccine was studied in Brazil, it was found that it is slightly more than 50%. The effectiveness of this vaccine is less than the effectiveness of the Cynofam vaccine, which reaches about 79% according to the results recorded in China, but it is worth noting that these results were not published in the results and research in scientific journals, and that may be For side effects of the vaccine. It should be noted that before adopting this vaccine, the results of the experiments must be carefully examined by competent researchers until we reach final recommendations regarding this vaccine. In order to reach herd immunity, there must be a positive immune response in 50 to 70% of people, and therefore a vaccine with 50% effectiveness will make it difficult for us to reach such results.

With another vaccine with higher efficacy such as Pfizer vaccine, Moderna vaccine, it will definitely be the beginning of our elimination of the monster Covid 19

Security and adequacy of the New Russian Vaccine"Sputnik-1"

Why it called like that?

The immunization was named after the primary Soviet satellite "Sputnik-1" in 1957, which was another driving force for space research around the globe, and framed the supposed "Sputnik second" for the worldwide local area.

Security and adequacy

 After the beginning of the pandemic, Russian analysts removed piece of the hereditary material for the arising SARS-COV-2 infection, which encodes information about the design of the S protein (the protein that shapes the "crown" of the infection and is answerable for its relationship with human cells), and they embedded it inside a vector known to them from Adenoviruses to convey it to the human cell, and in this manner the world's first immunization against SARS-COV-2 was found. To give long haul insusceptibility, Russian researchers have proposed utilizing two distinct sorts of adenovirus-based vectors in the first and second immunizations, which upgrades the viability of the antibody.

It is safe to use human adenoviruses as vectors, because these viruses that cause colds are not new, and they have been around for thousands of years. Studies data indicate that the effectiveness of the "Sputnik V" vaccine against Covid-19 is 91.6%. This number was obtained based on data from 19866 volunteers who received the first and second injections of "Sputnik V" or placebo, and 78 confirmed cases of Covid-19 infection were recorded during the last control and monitoring phase. The results of studies of efficacy of "Sputnik V" have passed the peer-review process on an international scale, and the data obtained are published in The Lancet.

    After reading this will you try Sputnik V?